Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results

Rhea-AI Summary

Artivion, Inc. (NYSE: AORT), a cardiac and vascular surgery company, will release its Q4 and full year 2023 financial results on February 15, 2024. A teleconference call and webcast will be held to discuss the results, hosted by Pat Mackin, the Chairman, President, and CEO. The press release will contain financial and statistical information for the completed quarter and full year.

ATLANTA, Feb. 1, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2023 financial results will be released on Thursday, February 15, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13742847. 

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:
Artivion	Gilmartin Group LLC
Lance A. Berry	Brian Johnston / Laine Morgan
Executive Vice President &	Phone: 332-895-3222
Chief Financial Officer	investors@artivion.com
Phone: 770-419-3355

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-fourth-quarter-and-full-year-2023-financial-results-302051170.html

SOURCE Artivion, Inc.

FAQ

When will Artivion release its Q4 and full year 2023 financial results?

Artivion will release its Q4 and full year 2023 financial results on Thursday, February 15, 2024 after the market closes.

Who will host the teleconference call and webcast to discuss the financial results?

The teleconference call and webcast to discuss the financial results will be hosted by Pat Mackin, the Chairman, President, and CEO of Artivion.

Where can the live webcast and replay be accessed?

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com by selecting Webcasts & Presentations.

What type of information will the earnings press release contain?

The earnings press release will contain financial and statistical information for the completed quarter and full year.